NinePoint Medical lands $34M for high-res organ imaging

NinePoint Medical touts a $34 million Series B funding round, slated to support U.S. commercial efforts for the company's NvisionVLE imaging system.

Massachusetts-based NinePoint Medical Imaging closed a $34 million Series B funding round, the company announced today.

NinePoint plans to use the funds to support ongoing U.S. commercial efforts for its NvisionVLE system, which provides high-res, endoscopic imaging of organs and tissues. The system can provide cross-sectional, volumetric views of organs, including tissues below the surface, the company said.

Corning Inc., NinePoint Medical Inc., Prospect Venture Partners, Third Rock Ventures LLC

News Well, Funding Roundup, Imaging, Personnel

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1nGGN4N